Securities adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) shares, with analyst Vamil Divan increasing the price target to $9.00 from the previous $6.00, while maintaining a Neutral rating on ...
KeyBanc Capital Markets sustained its Overweight rating for Meta Platforms Inc. (NASDAQ: NASDAQ:META), now trading at $676.49 ...
Wall Street researchers have revised their price targets for Tesla stock — at present, no clear consensus has emerged.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback